Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2023 | Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study | JOURNAL OF CLINICAL ONCOLOGY |